Glimpact Releases Top Environmental Tips for Super Bowl Watch Parties
February 09, 2024 19:20 ET
|
Glimpact
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Glimpact, a global platform to evaluate products’ and organizations’ environmental footprint, shares the findings of its study on popular Super Bowl...
LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE’s First-in-Class PP2A Inhibitor, LB-100, Plus GSK’s Immunotherapy, Dostarlimab, in Clear-Cell Ovarian Cancer
September 20, 2023 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
The Phase 1b Clinical Trial Focuses on Assessing the Safety and Efficacy of the Two-Drug Combination in a Cancer Associated with Longer Survival to Immunotherapy When Genetically Deficient in PP2A ...
Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance
September 06, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal...
ROSEN, TRUSTED INVESTOR COUNSEL, FIRM Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
August 19, 2023 17:52 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and...
Beyond Bitcoin: YouGov/FranShares Survey Finds Strong Interest in Alternative Assets
August 16, 2023 09:00 ET
|
FranShares
CHICAGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Younger investors don’t expect Lambo money. They’re not obsessed with crypto. But they are impatient, and they aren’t satisfied with traditional portfolios...
Atlas Salt Nears Feasibility Study for Great Atlantic Salt Project
July 24, 2023 08:00 ET
|
Atlas Salt Inc.
ST. JOHN’S, Newfoundland and Labrador, July 24, 2023 (GLOBE NEWSWIRE) -- Atlas Salt (the “Company” or “Atlas” - TSXV: SALT; OTCQB: REMRF; FSE: 9D00), owner of North America’s premier undeveloped...
New Study into Online Gambling Finds Link between Health Conditions and Excessive Screen Time
June 14, 2023 06:36 ET
|
Minimum Deposit Casinos
LONDON, June 14, 2023 (GLOBE NEWSWIRE) -- Leading iGaming brand, Minimum Deposit Casinos (MDC), has carried out a month-long comprehensive study analysing health concerns linked to online gambling...
Baptist Cancer Center research proves incidental lung nodule program effective in detecting cancer early
March 09, 2023 08:00 ET
|
Baptist Memorial Health Care
Memphis, TN, March 09, 2023 (GLOBE NEWSWIRE) -- Memphis-based Baptist Cancer Center published a JAMA Network Open article proving the effectiveness of incidental lung nodule, or tumor, programs in...
OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease
February 28, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye...
WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age
February 07, 2023 16:22 ET
|
WorldStrides
MELBOURNE, Australia and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- WorldStrides, the global leader in educational travel and experiential learning announced today its partnership with HEX, an...